EmpiraMed

EmpiraMed stands at the forefront of digital clinical technology, revolutionizing the way Real World Evidence (RWE) is captured in clinical trials and post-market studies through its innovative approach. The company harnesses the power of flexible, configurable plug-and-play modules within a unified cloud environment, enabling the seamless execution of decentralized and virtual clinical trials.

EmpiraMed’s technology is designed to streamline the operationalization of any clinical trial protocol, facilitating the rapid deployment of site-based, site-less, or hybrid models tailored to specific therapeutic areas. A key feature of EmpiraMed’s system is its unique participant-centered gamification and incentivization strategies, which significantly enhance participation and retention rates—achieving more than three times the industry standard. This approach not only engages participants more effectively but also dramatically increases the success rate of projects by ensuring higher levels of participant involvement and data collection fidelity. Through these innovations, EmpiraMed is redefining the landscape of clinical research, making it more efficient, engaging, and effective.